Related Experiment Video
Updated: Jul 27, 2025

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Catheter-Directed Thrombolysis Protocols for Deep Venous Thrombosis of the Lower Extremities-A Systematic Review and
Luís Duarte-Gamas1,2, Filipa Jácome1,2, Lara Romana Dias1,2
1Department of Angiology and Vascular Surgery, São João University Hospital Center, Porto, Portugal.
Insights
Catheter-directed thrombolysis (CDT) is a low-risk treatment for lower extremity deep venous thrombosis (LE-DVT). However, varied treatment protocols make assessing outcomes like post-thrombotic syndrome difficult.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Cardiology
Background:
- Lower extremity deep venous thrombosis (LE-DVT) is a significant vascular condition.
- Catheter-directed thrombolysis (CDT) is an emerging treatment option for LE-DVT.
- Understanding the efficacy and safety of various CDT protocols is crucial.
Purpose of the Study:
- To systematically review and summarize the characteristics, complications, and success rates of different catheter-directed thrombolysis (CDT) protocols for treating lower extremity deep venous thrombosis (LE-DVT).
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials and observational studies were conducted.
- Electronic databases (MEDLINE, Scopus, Web of Science) were searched for relevant LE-DVT and CDT studies.
- Pooled proportions of early complications, post-thrombotic syndrome (PTS), and venous patency were calculated using a random-effects model.
Main Results:
- Forty-six studies encompassing 49 protocols and 3,028 participants were analyzed.
- Iliofemoral involvement was present in 90% of LE-DVT cases.
- Pooled complication rates included minor bleeding (8.7%), major bleeding (1.2%), pulmonary embolism (1.1%), and death (0.6%).
- Pooled incidences of PTS and venous patency at 1 year were 17.6% and 77.5%, respectively.
Conclusions:
- Catheter-directed thrombolysis (CDT) demonstrates a low-risk profile for treating LE-DVT.
- Heterogeneity in CDT protocols complicates the assessment of outcomes, particularly post-thrombotic syndrome (PTS) rates.
- Further standardization of CDT protocols may improve outcome predictability.
Objective:
To summarize characteristics, complications, and success rates of different catheter-directed thrombolysis (CDT) protocols for the treatment of lower extremity deep venous thrombosis (LE-DVT).
Methods:
A systematic review using electronic databases (MEDLINE, Scopus, and Web of Science) was performed to identify randomized controlled trials and observational studies related to LE-DVT treated with CDT. A random-effects model meta-analysis was performed to obtain the pooled proportions of early complications, postthrombotic syndrome (PTS), and venous patency.
Results:
Forty-six studies met the inclusion criteria reporting 49 protocols (n = 3,028 participants). In studies that addressed the thrombus location (n = 37), LE-DVT had iliofemoral involvement in 90 ± 23% of the cases. Only four series described CDT as the sole intervention for LE-DVT, while 47% received additional thrombectomy (manual, surgical, aspiration, or pharmacomechanical), and 89% used stenting.Definition of venogram success was highly variable, being the Venous Registry Index the most used method (n = 19). Among those, the minimal thrombolysis rate (<50% lysed thrombus) was 0 to 53%, partial thrombolysis (50-90% lysis) was 10 to 71%, and complete thrombolysis (90-100%) was 0 to 88%. Pooled outcomes were 8.7% (95% confidence interval [CI]: 6.6-10.7) for minor bleeding, 1.2% (95% CI: 0.8-1.7%) for major bleeding, 1.1% (95% CI: 0.6-1.6) for pulmonary embolism, and 0.6% (95% CI: 0.3-0.9) for death. Pooled incidences of PTS and of venous patency at up to 1 year of follow-up were 17.6% (95% CI: 11.8-23.4) and 77.5% (95% CI: 68.1-86.9), respectively.
Conclusion:
Assessment of the evidence is hampered by the heterogeneity of protocols, which may be reflected in the variation of PTS rates. Despite this, CDT is a low-risk treatment for LE-DVT.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management

